Type I Interferons: Distinct Biological Activities and Current Applications for Viral Infection
The interferons (IFNs) are a primary defense against pathogens because of the strong antiviral activities they induce. IFNs can be classified into three groups: type I, type II and type III, according to their genetic, structural, and functional characteristics and their receptors on the cell surfac...
Saved in:
Published in | Cellular physiology and biochemistry Vol. 51; no. 5; pp. 2377 - 2396 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article Web Resource |
Language | English |
Published |
Basel, Switzerland
S. Karger AG
01.01.2018
Karger Cell Physiol Biochem Press GmbH & Co KG |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The interferons (IFNs) are a primary defense against pathogens because of the strong antiviral activities they induce. IFNs can be classified into three groups: type I, type II and type III, according to their genetic, structural, and functional characteristics and their receptors on the cell surface. The type I IFNs are the largest group and include IFN-α, IFN-β, IFN-ε, IFN-ω, IFN-κ, IFN-δ, IFN-τ and IFN-ζ. The use of IFNs for the treatment of viral infectious diseases on their antiviral activity may become an important therapeutic option, for example, IFN-α is well known for the successful treatment of hepatitis B and C virus infections, and interest is increasing in the antiviral efficacy of other novel IFN classes and their potential applications. Therefore, in this review, we summarize the recent progress in the study of the biological activities of all the type I IFN classes and their potential applications in the treatment of infections with immunodeficiency virus, hepatitis viruses, and influenza viruses. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Literature Review-3 ObjectType-Review-3 content type line 23 scopus-id:2-s2.0-85058602387 |
ISSN: | 1015-8987 1421-9778 1421-9778 |
DOI: | 10.1159/000495897 |